Date of event: estimated.Implant date: estimated.The devices were not returned for analysis.A review of the lot history records and complaint histories could not be conducted because the lot and part numbers were not provided.The patient effects listed are consistent with the product risk profile and are therefore expected.A conclusive cause for the difficulties listed cannot be determined based on the limited information available.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no corrective action is required.Article titled: "angiographically based direct implantation of the bioresorbable vascular scaffold in non-st segment elevation acute coronary syndrome: feasibility and outcome.".
|
It was reported through a research article identifying absorb scaffold that may be related to the following: myocardial infarction, dissection, in-stent thrombosis, chest pain, re-intervention and hospitalization.Details are listed in the article, titled ¿angiographically based direct implantation of the bioresorbable vascular scaffold in non-st segment elevation acute coronary syndrome: feasibility and outcome.¿.
|